Nomination period for the Broermann Medical Innovation Award started
The nomination period for the Broermann Medical Innovation Award has started. The prize, which will be awarded for the first ...
Viet Nam To Host The 16th United Nations Conference on Trade and Development In October 2025
UN Trade and Development (UNCTAD) Secretary-General Rebeca Grynspan announced today, that the sixteenth session of the United ...
Infosys and Tennis Australia Create New Generative AI Innovations at the Australian Open 2025
VR AI Stadium: The Infosys Fan Zone at Melbourne Park steps into the future, introducing a new VR AI Stadium where fans can ...
Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer
NEWS AKTUELL // Aachen, Germany, 09 January 2025 - Grünenthal announced today that Prof. Dr. Uli Brödl will assume the role ...
FEV develops AI-supported driver monitoring system CogniSafe
AI plays a pivotal role in the functions of FEV's latest development. Convolutional Neural Networks (CNN) are used to perform ...
Nescafé Espresso Concentrate expands to the US: enabling consumers to create customized, café-style, cold espresso bever
Nescafé Espresso Concentrate is made with 100% Arabica beans and comes in a 300-milliliter bottle (enough for approximately ...
SNP expands partnership with SAP
SNP SE, a leading software provider for digital transformation, automated data migration, and data management in SAP environments, is expanding its long-standing partnership with SAP, the global ...
Notimerica11d
BIAL Announces First Patient Out in its Phase 2 Clinical Trial of BIA 28-6156 - a Novel Therapy for GBA1 Parkinson's Dis
PORTO, Portugal, Jan. 7, 2025 /PRNewswire/ -- BIAL, a hundred-year-old innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, announced that the first patient has ...
LTS wins funding from BARDA's Patch Forward Prize Competition for two partnerships
Andernach - LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company, is proud to announces its ...
Unas 7.000 personas se manifiestan hasta las puertas de la Central Nuclear de Almaraz para reclamar su continuidad
Alrededor de 7.000 personas se manifiestado este sábado, según datos de la Guardia Civil, entre gritos de "no se cierra" y ...
Ancelotti responde a Simeone: "Supongo que son espinas que duelen"
También confirmó que David Alaba "está bien". "Jugó 40 minutos el jueves con buenas sensaciones. Le falta un poco el ritmo, ...
Rusia confirma el ataque nocturno a Kiev como una represalia por el uso de misiles de EEUU contra su territorio
El Ministerio de Defensa ruso ha manifestado que el ataque nocturno que ha dejado cuatro muertos en la región ucraniana de ...